Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal absorption and freckle-removing mechanism of freckle tight wrinkle essence in melasma
ChiCTR2200062086Phase 3Not yet recruiting
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in melasma comparing Placebo with Freckle tight wrinkle essence (2 arms). Primary endpoint: Melasma area and severity score (MASI). Planned start Jul 2022; status: not yet recruiting.
02
Drugs
Freckle Tight Wrinkle Essence
03
Conditions
melasma
Beyond the preview
Go deeper on ChiCTR2200062086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062086.